- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04337905
Virtual Reality (VR) Diagnostic Tool for Attention Deficits/Hyperactivity Disorder (ADHD) (New)
April 6, 2020 updated by: Tjhin Wiguna
A New Development Diagnostic Tool for ADHD: A VR Approach
Attention deficit/ hyperactivity disorder (ADHD) is a common neurodevelopmental disorder.
The common diagnostic of ADHD is based on psychiatric examination and interview.
So far, there is not any other diagnostic tool for ADHD nowadays.
Therefore, virtual reality (VR) technology can be used as a stimulus, replacing real stimuli, recreating experiences, which are in the real world would be impossible.
Consequently, ADHD-VR diagnostic tool development should be started to justify the ADHD diagnosis in psychiatric out-patient clinical services.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Diagnostic test is a very essential in modern medical practices, especially in child and adolescent psychiatry field because the main diagnostic tool is only based on psychiatry interview and observation.
Using Diagnostic tool can help a confirmation towards specific clinical diagnosis, provide more evidence for eliminating one diagnosis versus another, provide more evidence for parents, or to rule out the differential diagnosis.
Even though psychiatric examination is the main approach on ADHD diagnostic procedure, however the laboratory testing or imaging examination is also used especially to rule out the general medical condition or to find out any medical conditions that mimic ADHD but not to facilitate the ADHD diagnosis per se.
Nowadays, the expand study in biological psychiatry has found a lot of biological markers in ADHD as well; but none is really sensitive and specific for ADHD diagnostic test.
Therefore, there should be another approach for developing diagnostic tool in ADHD.
VR is one of the best approach bacasue these days, because VR as an ADHD diagnostic tool could create and replace real stimuli, recreating experiences, which could not be observed by the clinician at the out-patient clinic.
Study Type
Interventional
Enrollment (Anticipated)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
DKI Jakarta
-
Jakarta Pusat, DKI Jakarta, Indonesia, 10430
- Dr. Cipto Mangunkusumo General Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
6 years to 17 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria for ADHD group:
- Children with ADHD drug naive
- Parent willing to participate in the study by signing informed consent
- Children willing to participate the ADHD-VR diagnostic tool for at least 30 minutes
Exclusion Criteria:
- Having untreated chronic physical illnesses
- Having other mental disorders except ADHD
Inclusion Criteria for healthy children group:
- Do not have any mental disorder
- Do not have untreated chronic physical illnesses
- Parent willing to participate in the study by signing informed consent
- Children willing to participate the ADHD-VR diagnostic tool for at least 30 minutes
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Children with ADHD
Children with ADHD that running the ADHD-VR diagnostic test and also did the psychiatric examination to determine the ADHD diagnosis and to rule out other mental disorders
|
Since that time and in accordance with the application area, several definitions have been formulated: for example, Fuchs and Bishop (1992) defined VR as "real-time interactive graphics with 3D models, combined with a display technology that gives the user the immersion in the model world and direct manipulation"; Gigante (1993) described VR as "The illusion of participation in a synthetic environment rather than external observation of such an environment.
VR relies on a 3D, stereoscopic head-tracker displays, hand/body tracking and binaural sound.
VR is an immersive, multi-sensory experience"; and "Virtual reality refers to immersive, interactive, multi-sensory, viewer-centered, 3D computer generated environments and the combination of technologies required building environments".
|
Active Comparator: Children without ADHD
Healthy children that also running the ADHD-VR diagnostic test and also psyhchiatric examination to rule out the ADHD diagnosis and other mental disorders
|
Since that time and in accordance with the application area, several definitions have been formulated: for example, Fuchs and Bishop (1992) defined VR as "real-time interactive graphics with 3D models, combined with a display technology that gives the user the immersion in the model world and direct manipulation"; Gigante (1993) described VR as "The illusion of participation in a synthetic environment rather than external observation of such an environment.
VR relies on a 3D, stereoscopic head-tracker displays, hand/body tracking and binaural sound.
VR is an immersive, multi-sensory experience"; and "Virtual reality refers to immersive, interactive, multi-sensory, viewer-centered, 3D computer generated environments and the combination of technologies required building environments".
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The sensitivity and specificity of ADHD-VR diagnostic tool towards ADHD clinical symptoms
Time Frame: up to 30 minutes
|
The comparing between the ADHD-VR diagnostic test results and expert judgement on ADHD diagnosis
|
up to 30 minutes
|
The sensitivity and specificity of ADHD-VR diagnostic tool towards executive function
Time Frame: up to 30 minues
|
Comparing between the ADHD-VR diagnostic test results and Behavior Rating Inventory for Executive Function Rating Scale.
|
up to 30 minues
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Tjhin Wiguna, PhD, Dr Cipto Mangunkusumo General Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 25, 2019
Primary Completion (Anticipated)
December 31, 2020
Study Completion (Anticipated)
July 31, 2021
Study Registration Dates
First Submitted
April 3, 2020
First Submitted That Met QC Criteria
April 6, 2020
First Posted (Actual)
April 8, 2020
Study Record Updates
Last Update Posted (Actual)
April 8, 2020
Last Update Submitted That Met QC Criteria
April 6, 2020
Last Verified
April 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- ADHD-VR
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
IPD Plan Description
No decided yet
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on ADHD
-
The Hong Kong Polytechnic UniversityRecruiting
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH)Recruiting
-
VIZO Specs LtdRecruiting
-
Loewenstein HospitalWingate InstituteRecruiting
-
Florida State UniversityRecruiting
-
Florida International UniversityRecruiting
-
Region Örebro CountyRecruiting
-
Johns Hopkins UniversityWithdrawn
-
Tris Pharma, Inc.Premier Research Group plcCompleted
Clinical Trials on ADHD-VR diagnosis tool
-
Istanbul UniversityRecruiting
-
National Eye Institute (NEI)RecruitingCone-Rod Degeneration | Rod-Cone DegenerationUnited States, Australia
-
Changi General HospitalNational University Hospital, Singapore; Singapore General Hospital; Tan Tock...CompletedColonic Polyp | Colonic Neoplasms | Colonic DysplasiaSingapore
-
University of ManchesterNot yet recruiting
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingNeurodevelopmental Disorders
-
Nationwide Children's HospitalOhio State UniversityCompleted
-
Kessler FoundationCompletedAutism Spectrum Disorder | Autism | ASDUnited States
-
Weill Medical College of Cornell UniversityNational Institute on Aging (NIA)Not yet recruitingMild Cognitive ImpairmentUnited States